You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 265 No. 24, June 26, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Isolated Systolic Hypertension in the Elderly

Margaret A. Winker, MD; Michael B. Murphy, MD

JAMA. 1991;265(24):3301-3302.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Isolated systolic hypertension (ISH) affects up to two thirds of all individuals with hypertension between the ages of 65 and 89 years,1 and its prevalence, as estimated by the Systolic Hypertension in the Elderly Program (SHEP) Pilot Study, ranges from 6% of individuals aged 60 through 69 years to 18% of those aged 80 years or older.2 This extremely common disease is an independent risk factor for the development of cerebrovascular and cardiovascular morbidity and mortality, and, in the Framingham Study, it was the single greatest risk factor other than age for the development of cardiovascular disease in the elderly population.3

Isolated systolic hypertension is believed to result from the pathophysiology of aging, which includes decreased connective tissue elasticity and atherosclerosis, resulting in increased peripheral vascular resistance,4 and diminished β2 receptor sensitivity, leading to decreased smooth muscle relaxation.5 Because of the presumed irreversible "stiffening" . . . [Full Text PDF of this Article]


Author Affiliations

From the Section of General Internal Medicine (Dr Winker), Department of Medicine (Drs Winker and Murphy), and the Committee on Clinical Pharmacology (Drs Winker and Murphy), University of Chicago (Ill) Medical Center.


Footnotes

Reprint requests to Section of General Internal Medicine, Department of Medicine, University of Chicago Medical Center, 5841 S Maryland Ave, Room M640, Box 72, Chicago, IL 60637 (Dr Winker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.